Annual Net Income
-$255.10 M
-$89.10 M-53.67%
December 31, 2023
Summary
- As of February 10, 2025, TXG annual net profit is -$255.10 million, with the most recent change of -$89.10 million (-53.67%) on December 31, 2023.
- During the last 3 years, TXG annual net income has risen by +$287.63 million (+53.00%).
- TXG annual net income is now -1259.66% below its all-time high of -$18.76 million, reached on December 31, 2017.
Performance
TXG Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$35.75 M
+$2.14 M+5.66%
September 30, 2024
Summary
- As of February 10, 2025, TXG quarterly net profit is -$35.75 million, with the most recent change of +$2.14 million (+5.66%) on September 30, 2024.
- Over the past year, TXG quarterly net income has increased by +$57.23 million (+61.55%).
- TXG quarterly net income is now -883.31% below its all-time high of -$3.64 million, reached on March 31, 2019.
Performance
TXG Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$182.55 M
+$57.23 M+23.87%
September 30, 2024
Summary
- As of February 10, 2025, TXG TTM net profit is -$182.55 million, with the most recent change of +$57.23 million (+23.87%) on September 30, 2024.
- Over the past year, TXG TTM net income has increased by +$40.81 million (+18.27%).
- TXG TTM net income is now -1089.64% below its all-time high of -$15.35 million, reached on September 30, 2018.
Performance
TXG TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TXG Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.7% | +61.5% | +18.3% |
| 3 y3 years | +53.0% | -93.8% | -213.5% |
| 5 y5 years | -126.8% | -401.2% | -484.1% |
TXG Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -338.1% | at low | -107.7% | +61.5% | -213.5% | +30.9% |
| 5 y | 5-year | -716.3% | +53.0% | -401.2% | +91.4% | -484.1% | +66.4% |
| alltime | all time | -1259.7% | +53.0% | -883.3% | +91.4% | -1089.6% | +66.4% |
10x Genomics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$35.75 M(-5.7%) | -$182.55 M(-23.9%) |
| Jun 2024 | - | -$37.90 M(-36.8%) | -$239.78 M(-9.3%) |
| Mar 2024 | - | -$59.95 M(+22.5%) | -$264.30 M(+3.6%) |
| Dec 2023 | -$255.10 M(+53.7%) | -$48.95 M(-47.4%) | -$255.10 M(+14.2%) |
| Sep 2023 | - | -$92.99 M(+49.0%) | -$223.36 M(+29.6%) |
| Jun 2023 | - | -$62.41 M(+23.0%) | -$172.29 M(-1.2%) |
| Mar 2023 | - | -$50.75 M(+194.8%) | -$174.33 M(+5.0%) |
| Dec 2022 | -$166.00 M(+185.1%) | -$17.21 M(-58.9%) | -$166.00 M(-0.7%) |
| Sep 2022 | - | -$41.91 M(-35.0%) | -$167.23 M(+17.4%) |
| Jun 2022 | - | -$64.46 M(+52.0%) | -$142.49 M(+59.9%) |
| Mar 2022 | - | -$42.41 M(+129.9%) | -$89.08 M(+53.0%) |
| Dec 2021 | -$58.22 M | -$18.45 M(+7.4%) | -$58.22 M(-87.2%) |
| Sep 2021 | - | -$17.17 M(+55.4%) | -$455.35 M(-9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$11.05 M(-4.3%) | -$504.02 M(-5.5%) |
| Mar 2021 | - | -$11.55 M(-97.2%) | -$533.14 M(-1.8%) |
| Dec 2020 | -$542.73 M(+1636.7%) | -$415.57 M(+531.1%) | -$542.73 M(+304.1%) |
| Sep 2020 | - | -$65.85 M(+63.9%) | -$134.29 M(+72.1%) |
| Jun 2020 | - | -$40.17 M(+90.0%) | -$78.05 M(+60.1%) |
| Mar 2020 | - | -$21.14 M(+196.4%) | -$48.76 M(+56.0%) |
| Dec 2019 | -$31.25 M(-72.2%) | -$7.13 M(-25.7%) | -$31.25 M(-68.6%) |
| Sep 2019 | - | -$9.60 M(-11.7%) | -$99.64 M(-5.4%) |
| Jun 2019 | - | -$10.88 M(+199.2%) | -$105.38 M(+11.5%) |
| Mar 2019 | - | -$3.64 M(-95.2%) | -$94.50 M(+4.0%) |
| Dec 2018 | -$112.48 M(+499.5%) | -$75.52 M(+392.2%) | -$90.87 M(+492.2%) |
| Sep 2018 | - | -$15.35 M | -$15.35 M |
| Dec 2017 | -$18.76 M | - | - |
FAQ
- What is 10x Genomics annual net profit?
- What is the all time high annual net income for 10x Genomics?
- What is 10x Genomics annual net income year-on-year change?
- What is 10x Genomics quarterly net profit?
- What is the all time high quarterly net income for 10x Genomics?
- What is 10x Genomics quarterly net income year-on-year change?
- What is 10x Genomics TTM net profit?
- What is the all time high TTM net income for 10x Genomics?
- What is 10x Genomics TTM net income year-on-year change?
What is 10x Genomics annual net profit?
The current annual net income of TXG is -$255.10 M
What is the all time high annual net income for 10x Genomics?
10x Genomics all-time high annual net profit is -$18.76 M
What is 10x Genomics annual net income year-on-year change?
Over the past year, TXG annual net profit has changed by -$89.10 M (-53.67%)
What is 10x Genomics quarterly net profit?
The current quarterly net income of TXG is -$35.75 M
What is the all time high quarterly net income for 10x Genomics?
10x Genomics all-time high quarterly net profit is -$3.64 M
What is 10x Genomics quarterly net income year-on-year change?
Over the past year, TXG quarterly net profit has changed by +$57.23 M (+61.55%)
What is 10x Genomics TTM net profit?
The current TTM net income of TXG is -$182.55 M
What is the all time high TTM net income for 10x Genomics?
10x Genomics all-time high TTM net profit is -$15.35 M
What is 10x Genomics TTM net income year-on-year change?
Over the past year, TXG TTM net profit has changed by +$40.81 M (+18.27%)